Somewhere in the quiet chemistry of the bloodstream, a small molecule called CtBP2 may be carrying a message about how the body grows old. Researchers at the University of Tsukuba have found that its levels drift downward with the years, sit lower in people wrestling with serious diabetes complications, and rise among those born into long-lived families. Long assumed to work only within cells, it turns out to travel, helping to keep metabolism steady across distant organs. If its promise holds, it may one day offer a way to read a person's biological age, though whether it can be safely nudged
Blood Molecule CtBP2 May Link Body-Wide Aging to Longevity and Could Enable Simple Aging Tests
When one system begins to age, others may follow.
Mark
What is the headline idea here?
Mimi
That aging may be coordinated across the body, and that one blood molecule, CtBP2, might reflect it. It helps regulate metabolism, and its levels drop with age.
Mark
Why does it matter that it's in the blood?
Mimi
It was thought to work only inside cells. The team found it is released outside the cell when activated, which makes it measurable, and that is what opens the door to a blood test.
Luke
Careful with the causal language, though. Lower levels go along with age and diabetes complications. Does the reporting show that low CtBP2 drives aging?
Mimi
The researchers say disrupted activity can trigger systemic aging, but what we're given is that claim and the correlations, not the underlying evidence.
Mark
And the long-lived families?
Mimi
They consistently showed higher levels. That's an association with longevity, not proof of a cause.
Luke
We also don't know the sample sizes, how the groups were chosen, or how well the test predicts anything for an individual. None of that is in the summary.
Mark
So what's solid?
Luke
That a method to measure it exists and that the patterns were observed. Personalized strategies and boosting CtBP2 are stated as possibilities for future research.
Mimi
Which is how the researchers frame it too: someday, if validated.
Le Pouls
- A molecule once thought to stay inside cells has been found circulating in the blood, quietly tying metabolic health to the pace of aging.
- Its levels fall as people grow older and dip further in those suffering advanced diabetes complications, raising alarm about how widely decline spreads.
- Researchers are developing blood measurements to see whether CtBP2 can serve as a practical gauge of biological age.
- Families with long lifespans show higher levels, but whether boosting the molecule can slow decline without harm is still unanswered and untested in people.
Somewhere in the quiet chemistry of the bloodstream, a small molecule called CtBP2 may be carrying a message about how the body grows old. Researchers at the University of Tsukuba have found that its levels drift downward with the years, sit lower in people wrestling with serious diabetes complications, and rise among those born into long-lived families. Long assumed to work only within cells, it turns out to travel, helping to keep metabolism steady across distant organs. If its promise holds, it may one day offer a way to read a person's biological age, though whether it can be safely nudged upward remains a question still waiting its turn.
At the University of Tsukuba in Japan, a team has turned its attention to a molecule called CtBP2, and what they found suggests that aging may travel through the body as a single, connected story rather than a collection of separate failures. The researchers observed that CtBP2 levels in the blood decline as people age, run lower in those with serious diabetes complications, and run higher in people who come from long-lived families.
The scientists first came to CtBP2 through their study of obesity and metabolism. It acts as a sensor that responds to changes in how the body handles energy, and earlier work had shown its activity falls in people with obesity and metabolic syndrome. Its activation had also produced beneficial metabolic effects. Their newer discovery was that CtBP2, long believed to function only inside cells, is released into the bloodstream when activated, where it helps maintain metabolic balance throughout the body. When its activity is disrupted, they report, the consequences can include systemic aging and more health problems.
To test this in people, the team built a method for measuring CtBP2 in blood samples. The patterns they saw supported the idea that the molecule could serve as a biomarker of both aging and general health. Two paths now lie ahead: using the test to estimate a person's biological age and guide personalized care, and exploring whether CtBP2 can be safely raised to slow age-related decline. Neither is ready for clinical use, and the work of validating the test and proving that boosting the molecule is safe is only beginning.
A team at the University of Tsukuba in Japan has pointed to a single molecule in the blood as a possible thread connecting aging across the whole body. The molecule is called CtBP2, and the researchers report that its levels fall as people get older, run lower in people with serious diabetes complications, and run higher in people who come from long-lived families.
The starting premise is familiar to anyone who has looked in a mirror. Wrinkles and gray hair on the surface tend to mirror changes happening inside the organs, which suggests aging is not a set of isolated events. It spreads in a coordinated way, so that when one system begins to age, others may follow.
The Tsukuba group came to CtBP2 while studying how obesity and metabolism are linked. CtBP2 works as a sensor that responds to metabolic changes. Earlier research had already shown that its activity declines in people with obesity, which can contribute to metabolic syndrome. Earlier work had also shown that stimulating or activating CtBP2 produces therapeutic effects that improve metabolism.
The team then looked more closely at how the molecule behaves. They found that CtBP2, long thought to operate only inside cells, is released outside the cell when it is activated. Once it is present in the bloodstream, it helps keep metabolism healthy throughout the body. When its activity is disrupted, the researchers say, the result can be systemic aging and a rise in health problems. That finding supports the view of aging as an interconnected, body-wide process.
To test the idea in people, the researchers developed a method for measuring CtBP2 in blood samples. Levels tended to decline with age. People from long-lived families consistently showed higher concentrations. Individuals with advanced diabetes complications showed notably lower ones. Together, the results suggest that blood CtBP2 could serve as a biomarker of both biological aging and general health.
The team sees two possible paths forward. One is diagnostic: using CtBP2 as an indicator, doctors and scientists might one day estimate a person's aging status and build personalized health strategies around it. The other is therapeutic: future studies could explore how to safely boost CtBP2 secretion into the blood to slow age-related decline and improve well-being. Neither is available now, and the second remains an open question.
The work was funded by the Japan Society for the Promotion of Science (grants 20K08855 and 23K18270 to M.S.), the Japan Agency for Medical Research and Development (AMED, grants JP18gm5910007, JP25gm6710004 and JP22ek0210175), the Takeda Science Foundation, the Ono Medical Research Foundation, the Manpei Suzuki Diabetes Foundation and the Japan Diabetes Foundation.
What to watch for is validation: whether the blood test holds up as a measure of biological age, and whether raising CtBP2 can be done safely.
Citations marquantes
CtBP2 in the blood could serve as a useful biomarker for assessing both biological aging and overall health.— University of Tsukuba research team (paraphrased)
Envie de l'histoire complète ?
Lire l'original sur ScienceDaily ↗
Science & Space